Multiple Manufacturers

BETASERON

Manufacturer:

Multiple Manufacturers

Betaseron HCPCS:

J1830

HCPCS Code Descriptor:

Injection, interferon beta-1b, 0.25 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)

Category:

J Code

Betaseron NDCs:

50419-0523-25, 50419-0523-35, 00078-0569-12, 50419-0524-35, 00078-0569-61, 50419-0524-01

Primary Type:

Neurology

Generic/Specialty Status:

Multi-Source

Package Type:

Multiple

Route of Administration:

Subcutaneous

Betaseron CPT Codes:

Potential CPT administration codes for Betaseron can be found at the following link.

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

50419-0523-25, 50419-0523-35, 00078-0569-12, 00078-0569-61

About Betaseron:

BETASERON is a medication manufactured by multiple manufacturers and aligned to the J Code: J1830. BETASERON is administered via the subcutaneous route of administration.

ACCESS PRICING AND MORE BY REGISTERING

J1830 Added Date:

January 1, 1982

J1830 Effective Date:

January 1, 2023

J1830 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Betaseron billing and coding information.
Betaseron patient assistance information can be found through Bayer Patient Assistance at the URL: https://www.patientassistance.bayer.us/
BETASERON prescribing information can be found at the link below. Please reach out to us if you believe this information to be innacurate or out of date.
Our team has not yet identified a source of side effects information for BETASERON. Please check back in a few weeks.